文献速递口腔正畸

口腔正畸领域Cochrane与非Cochrane荟萃分析异质性差异研究

Heterogeneity in Cochrane and non-Cochrane meta-analyses in orthodontics.
PubMed 文献 · J Dent · 2018-05-05

该研究检索2000年至2017年五本正畸期刊及Cochrane系统评价数据库,纳入72篇系统评价共391项荟萃分析,评估异质性(I²)与各研究特征的关系。结果显示32%的荟萃分析I²=0%,39%的荟萃分析I²在60%至100%之间,每增加一项研究,异质性升高20%,固定效应分析则显著降低异质性。

要点

  • 正畸荟萃分析中约39%存在高异质性(I²约60%至100%)。
  • 每增加一项纳入研究,高异质性几率增加20%。
  • 使用固定效应分析可显著降低高异质性几率。

核心结论

  • 大量正畸荟萃分析存在显著的统计学异质性。
  • 需更审慎地决定是否进行荟萃分析及选择纳入研究。

研究设计与样本

  • 检索2000年1月至2017年12月五本正畸期刊和Cochrane系统评价数据库。
  • 纳入至少含一项荟萃分析的系统评价,共72篇系统评价、391项荟萃分析。
  • 其中非Cochrane系统评价54篇,占75%。
  • 采用单变量和多变量混合效应序数逻辑回归分析异质性预测因素。

主要发现

  • 125项荟萃分析(32%)报告异质性由偶然性解释(I²=0%)。
  • 152项荟萃分析(39%)报告高异质性(I²约60%至100%)。
  • 每增加一项纳入研究,高异质性几率增加20%(OR=1.20;95%CI:1.09,1.31;p<0.001)。
  • 使用固定效应分析显著降低高异质性几率(OR=0.25;95%CI:0.12,0.55;p=0.001)。
  • Cochrane与非Cochrane荟萃分析在高异质性几率上无显著差异(OR=2.81;95%CI:0.53,14.91;p=0.22)。

关键数值与推荐

  • 异质性(I²)分为四类:0%、1%至29%、30%至59%、60%至100%。
  • 高异质性定义为I²约60%至100%。

临床怎么用

  • 临床解读正畸荟萃分析时应关注其异质性大小。
  • 减少异质性可提高证据可靠性,支持更坚实的临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Heterogeneity describes the percentage of variability across the study effects that can be attributed to between-study differences in a meta-analysis. The aim of this project was to explore the magnitude of heterogeneity in Cochrane and non-Cochrane meta-analyses in orthodontic research and to identify possible associations between heterogeneity (I2) and a number of study characteristics including number of studies, type of outcome and type of analysis. METHODS: The contents of five major orthodontic journals and the Cochrane Database of Systematic Reviews were electronically searched from January 2000 to December 2017 to identify Systematic Reviews (SRs) with at least one meta-analysis. Included records were screened for reporting of I2 classified into four categories: 0%, 1-29%, 30-59%, 60-100%. Associations between I2 and review-level and synthesis-level characteristics were tested. Univariable and multivariable mixed effects ordinal logistic regression was used to identify significant predictors for statistical heterogeneity. RESULTS: A total of 72 SRs comprising 391 meta-analyses were included with the majority based on non-Cochrane reviews (n = 54, 75%). Overall, 125 meta-analyses (32%) reported heterogeneity explained by chance (I2 = 0%), whereas high values of I2 (∼60-100%) were seen in 152 syntheses (39%). In the multivariable analysis, inclusion of each additional study within the synthesis presented 20% higher odds for substantial/considerable heterogeneity compared to lower heterogeneity categories (OR = 1.20; 95%CIs: 1.09, 1.31; p < 0.001). Use of fixed effect analysis (OR = 0.25; 95%CIs: 0.12, 0.55; p = 0.001) was associated with significantly lower odds. Cochrane versus non-Cochrane meta-analyses were not associated with higher odds for substantial/considerable heterogeneity (OR = 2.81; 95%CIs: 0.53, 14.91; p = 0.22). CONCLUSIONS: Substantial statistical heterogeneity is present within a considerable number of orthodontic meta-analyses. Further efforts should be made to improve understanding of decisions to undertake meta-analyses and selection of studies eligible for inclusion. CLINICAL SIGNIFICANCE: The consistency of meta-analyses could be improved with more careful consideration of individual study characteristics. Reduced heterogeneity in meta-analyses will ensue more solid evidence based decisions for clinical practice.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Koletsi D, Fleming PS, Michelaki I, et al. Heterogeneity in Cochrane and non-Cochrane meta-analyses in orthodontics. J Dent. 2018. PMID: 29738788. doi:10.1016/j.jdent.2018.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。